| Real Life Solutions Next Generation Drug Delivery System by SHL | ||||
|
|
Issued by: KraussMaffei Issued on: 2009/01/04 The background For over 14 years, Scandinavian Health Limited (SHL), has designed, developed and supplied advanced drug delivery systems for the international pharmaceutical and biotech industries. KraussMaffei partnered with SHL to implement production of a new disposable auto-injector. The product The Disposable Auto-Injectior DAI™ enables patients to easily and efficiently inject themselves with drugs to treat a range of illnesses. The device consists of approximately 10 plastic components produced exclusively on KraussMaffei machines. The challenge The SHL Group must be able to mass-produce product components, uphold stringent quality standards and maintain absolute reliability of the product, producing 24 hours a day, 365 days a year. In order to achieve this, production systems had to meet SHL’s detailed specifications for all components and the whole production infrastructure had to be certified to the required standards. The solution KraussMaffei supplied cleanroom production cells precisely to the customer’s specifications. The CX CleanForm injection moulding machines in different tonnages were fully certified as to product quality and performance. The production cells met all the customer specifications – from permissible component types to noise emissions and shot weight tolerances for the injection moulding machines. The outcome SHL, a leader in the global market, produces disposable auto-injectors for its customers in very high volumes. The company now operates over 100 machines engineered to the specifications that were drawn up in consultation with KraussMaffei. The constant delivery of excellent products has become a hallmark of the group’s operations and a benchmark in the advanced drug delivery industry. “As a global provider of drug delivery systems, strictly reproducible product quality is necessary for our existence.We have a policy of zero error tolerance and our partners have to share this thinking. KraussMaffei is such a partner.” Roger Samuelsson, CEO and founder of the SHL Group About SHL SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,500 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities. Our organization consists of three distinct group companies:
SHL Medical SHL Healthcare SHL Technologies For additional information visit www.shl-group.com or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it SHL Media ContactSteven R. Kaufman Marketing Director +886 932 111 460 This e-mail address is being protected from spambots. You need JavaScript enabled to view it |